Sep 9, 2021 | CARDIORENAL
Part One 2) This program is intended for healthcare professionals and is supported by educational grants from AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company, Chiesi, and NovoNordisk. See archived programs at...
Sep 1, 2021 | CARDIORENAL
1) Welcome to a new joint-accredited #tweetorial on the very foundation of the new “specialty” of #cardiometabolic medicine: organ crosstalk. I am @md_pollack. Follow this tweetorial to earn FREE 0.5h credit, #physicians #nurses #pharmacists!...
Jul 7, 2021 | CARDIORENAL
This accredited educational program is intended for healthcare providers only, and is supported by grants from AstraZeneca, Bayer, Chiesi, and NovoNordisk. Follow this thread for a link to credit. CE/#CME credit for #physicians, #nurses, #pharmacists in US, Canada,...
May 27, 2021 | CARDIORENAL
1) Welcome to a Tweetorial on #SGLT2i & CV health. “Flozinators of the world, unite!” Accredited for 0.50h by @academiccme: #physicians, #nurses, #pharmacists. I am @mvaduganathan . . . pic.twitter.com/2yfGOqmStm— cardio-met (@cardiomet_CE) May 25, 2021 2)...
May 13, 2021 | CARDIORENAL
1) Welcome to a tweetorial on GLP-1 RAs, CV outcomes, obesity mgt, & T2D! Accredited for 0.50h by @academiccme: physicians, nurses, pharmacists! I am @CMichaelGibson . . .— cardio-met (@cardiomet_CE) May 11, 2021 2) Here’s a case. 47M dx’d T2D 4y ago by PCP. On...
May 6, 2021 | CARDIORENAL
1) Welcome to a joint-accredited tweetorial on a new therapeutic option to reduce the progression of diabetic kidney disease: finerenone – a non-steroidal mineralocorticoid receptor antagonist. I am @drkevinfernando. #FOAMed pic.twitter.com/qMnX0VWiuL— cardio-met...